{
  "symbol": "GILD",
  "year": 2023,
  "Period": "Q2",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.0836,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.324
  },
  "top_positive": [
    {
      "sent": "The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: June 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 23 Other current liabilities $ 34 Foreign currency exchange contracts Other long-term assets 2 Other long-term obligations 2 Total derivatives designated as hedges 24 36 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities \u2014 Total derivatives not designated as hedges 1 \u2014 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 25 $ 36 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 19 ) ( 19 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 6 $ 17 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Six Months Ended June 30, June 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: Net gain (loss) recognized in Accumulated other comprehensive income $ 5 $ 102 $ ( 1 ) $ 130 Net gain reclassified from Accumulated other com\ne year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
      "score": 0.9923
    },
    {
      "sent": "2022 Equity Incentive Plan (14) 10.4* Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2011 through 2018) (15) 10.5* Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2019) (16) 10.6* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2019) (17) 10.7* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2020) (18) 10.8* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2021) (19) 10.9* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for certai",
      "score": 0.9907
    },
    {
      "sent": "The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 44 $ 75 Short-term marketable debt securities 963 973 Long-term marketable debt securities 1,334 1,245 Total $ 2,341 $ 2,293 15 The following table summarizes our available-for-sale debt securities by contractual maturity: June 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
      "score": 0.984
    }
  ],
  "top_negative": [
    {
      "sent": "DEBT AND CREDIT FACILITIES The following table summarizes the carrying amount of our borrowings under various financing arrangements: (in millions) Carrying Amount Type of Borrowing Issue Date Maturity Date Interest Rate June 30, 2023 December 31, 2022 Senior Unsecured September 2016 September 2023 2.50 % $ 750 $ 749 Senior Unsecured September 2020 September 2023 0.75 % 1,499 1,498 Senior Unsecured March 2014 April 2024 3.70 % 1,749 1,748 Senior Unsecured November 2014 February 2025 3.50 % 1,749 1,748 Senior Unsecured September 2015 March 2026 3.65 % 2,743 2,742 Senior Unsecured September 2016 March 2027 2.95 % 1,248 1,247 Senior Unsecured September 2020 October 202\nalid and enforceable patents, and successfully prove infringement of those patents by our HCV products, we could be required to pay significant monetary damages.",
      "score": -0.9382
    },
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.91
    },
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.91
    }
  ],
  "forward_snippets": [
    "We believe this presentation assists users of the financial statements to better understand cash flow movements.",
    "We do not currently intend to sell, and it is not more likely than not that we will be required to sell, such investments before recovery of their amortized cost bases.",
    "The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 44 $ 75 Short-term marketable debt securities 963 973 Long-term marketable debt securities 1,334 1,245 Total $ 2,341 $ 2,293 15 The following table summarizes our available-for-sale debt securities by contractual maturity: June 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
    "The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: June 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 23 Other current liabilities $ 34 Foreign currency exchange contracts Other long-term assets 2 Other long-term obligations 2 Total derivatives designated as hedges 24 36 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities \u2014 Total derivatives not designated as hedges 1 \u2014 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 25 $ 36 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 19 ) ( 19 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 6 $ 17 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Six Months Ended June 30, June 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: Net gain (loss) recognized in Accumulated other comprehensive income $ 5 $ 102 $ ( 1 ) $ 130 Net gain reclassified from Accumulated other com\ne year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
    "Outside the U.S., we will commercialize the product and Arcellx will receive royalties on sales."
  ],
  "curated_text": "Symbol: GILD. Year: 2023. Period: Q2. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: June 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 23 Other current liabilities $ 34 Foreign currency exchange contracts Other long-term assets 2 Other long-term obligations 2 Total derivatives designated as hedges 24 36 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities \u2014 Total derivatives not designated as hedges 1 \u2014 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 25 $ 36 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 19 ) ( 19 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 6 $ 17 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Six Months Ended June 30, June 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: Net gain (loss) recognized in Accumulated other comprehensive income $ 5 $ 102 $ ( 1 ) $ 130 Net gain reclassified from Accumulated other com\ne year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments. 2022 Equity Incentive Plan (14) 10.4* Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2011 through 2018) (15) 10.5* Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2019) (16) 10.6* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2019) (17) 10.7* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2020) (18) 10.8* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2021) (19) 10.9* Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for certai The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 44 $ 75 Short-term marketable debt securities 963 973 Long-term marketable debt securities 1,334 1,245 Total $ 2,341 $ 2,293 15 The following table summarizes our available-for-sale debt securities by contractual maturity: June 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments. Top negative sentences: DEBT AND CREDIT FACILITIES The following table summarizes the carrying amount of our borrowings under various financing arrangements: (in millions) Carrying Amount Type of Borrowing Issue Date Maturity Date Interest Rate June 30, 2023 December 31, 2022 Senior Unsecured September 2016 September 2023 2.50 % $ 750 $ 749 Senior Unsecured September 2020 September 2023 0.75 % 1,499 1,498 Senior Unsecured March 2014 April 2024 3.70 % 1,749 1,748 Senior Unsecured November 2014 February 2025 3.50 % 1,749 1,748 Senior Unsecured September 2015 March 2026 3.65 % 2,743 2,742 Senior Unsecured September 2016 March 2027 2.95 % 1,248 1,247 Senior Unsecured September 2020 October 202\nalid and enforceable patents, and successfully prove infringement of those patents by our HCV products, we could be required to pay significant monetary damages. Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts. Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts. Forward-looking snippets: We believe this presentation assists users of the financial statements to better understand cash flow movements. We do not currently intend to sell, and it is not more likely than not that we will be required to sell, such investments before recovery of their amortized cost bases. The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 44 $ 75 Short-term marketable debt securities 963 973 Long-term marketable debt securities 1,334 1,245 Total $ 2,341 $ 2,293 15 The following table summarizes our available-for-sale debt securities by contractual maturity: June 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments. The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: June 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 23 Other current liabilities $ 34 Foreign currency exchange contracts Other long-term assets 2 Other long-term obligations 2 Total derivatives designated as hedges 24 36 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities \u2014 Total derivatives not designated as hedges 1 \u2014 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 25 $ 36 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 19 ) ( 19 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 6 $ 17 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Six Months Ended June 30, June 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: Net gain (loss) recognized in Accumulated other comprehensive income $ 5 $ 102 $ ( 1 ) $ 130 Net gain reclassified from Accumulated other com\ne year $ 1,014 $ 1,007 After one year through five years 1,332 1,313 After five years through ten years 17 16 After ten years 4 4 Total $ 2,367 $ 2,341 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,253 $ 3,831 Prepaid and other current assets (1) 431 473 Other long-term assets (1) 1,046 943 Total $ 5,730 $ 5,248 ________________________________ (1) Prepaid and other current assets and Other long-term assets include our equity method investments in Arcus and Galapagos, respectively, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments. Outside the U.S., we will commercialize the product and Arcellx will receive royalties on sales."
}